Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Psychiatric University Hospital, Zurich
The present study seeks to investigate the potential to pharmacologically modulate slow-wave sleep in the acute aftermath of an experimentally-induced trauma in the interest of developing a secondary prevention of posttraumatic stress disorder. The effects of a GABAergic compound will be compared with that of a noradrenergic compound. Memory, sleep and stress-related immune response factors will be quantified and compared across drug conditions.
Age
18–35
Sex
MALE
Healthy volunteers
Accepted
You may be eligible if
Speaks and understands German
BMI 18.5 -\< 25
Non-smoker status
Habitual 5 or fewer alcoholic beverages / week
Habitual 3 or fewer caffeinated beverages / day
Habitual average sleep duration 7-9 h / night
Normal or corrected-to-normal vision
Insomnia Severity Index score between 8-14
You may not be if
Travel across 3 or more time zones within 3 months of study start
Habitual napping
Extreme chronotype, determined by Morningness-Eveningness Questionnaire
History of or presence of a trauma- or stressor-related disorder
History of or presence of neurological disorder, psychiatric disorder or head injury
History of or presence of a sleep disorder
History of or presence of cardiovascular disorder
Use of illicit drugs
Atypical preference for excessively violent portrayals
Faints at the site of blood or brutality
Has participated in a study \< 30 days or a study such as this (i.e., experimental trauma) at all.
